Clinical Trial Update: Evaluation of Retinal Changes in Systemic Darbepoetin Alpha Treatment in Patients With Diabetes Mellitus

View source ↗

Summary

The clinical trial evaluated retinal changes in patients with diabetes mellitus treated with systemic darbepoetin alfa; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Medical University of Vienna | Conditions: Diabetic Retinopathy | Status: TERMINATED